VIDA Global (VIDA) Stock Analysis & Winston Score

Winston Score History

VIDA Global Inc. is a small technology company that uses artificial intelligence to analyze medical images, particularly chest X-rays and CT scans. Its software helps doctors and hospitals detect diseases like lung cancer and chronic obstructive pulmonary disease (COPD) more quickly. The company sells its tools to healthcare providers, research institutions, and pharmaceutical companies running clinical trials.

VIDA makes money by licensing its AI software platform to customers, primarily in the United States. With a market cap of around $100 million, it is a very small player in the medical imaging software space, competing against much larger companies with deeper resources. The company is currently losing a significant amount of money relative to its revenue, as shown by its deeply negative operating margin, and its main challenge is scaling up sales fast enough to reach profitability before it runs out of runway.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+758.1% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

-112.8% YoY

YoY Growth Rate

Earnings declining

Insider Activity

74.7%ownership

↓ Declining

Insider ownership declining — could be dilution or selling

Cash Runway

~7 months

$2M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Revenue accelerating

VIDA Global grew revenue 758% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

52.1%

Healthy — 52.1% gross margin

Profit after running costs

Operating Margin

-289.8%

Losing money on operations — -289.8%

Return on the money invested

ROCE

-18.2%

Weak — -18.2% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

Data not available

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial